Individualized ocular characteristics should be considered before starting GLP-1 RA therapies for weight loss and diabetes ...

Five years after a police chase left him with life-altering injuries, Travis Felton says the financial settlement he received ...

The longer weight loss GLP-1 drugs like Ozempic and Wegovy have been on the market, the more side effects people are ...

Discover new treatments like ART-123 advancing toward approval to prevent long-term nerve damage caused by ...

Recent research introduces a soft, injectable material designed for use in the eye to help protect and support damaged ...

The drugs, sutezolid and delpazolid, have demonstrated strong antimicrobial activity and a notably better safety profile ...

Conclusion: Diabetic neuropathy is a many-faceted complication of diabetes that can be managed symptomatically with an array of drugs.

The drugs, sutezolid and delpazolid, have demonstrated strong antimicrobial activity and a notably better safety profile ...

Journavx is the first truly new painkiller approved by the Food and Drug Administration in more than 20 years. But the drug is expensive, and many people can't get it yet.

Individualized ocular characteristics should be considered before starting GLP-1 RA therapies for weight loss and diabetes management.

The drug is now available for prescription in New Zealand but there are clouds to go along with the silver linings - such as ...

The success of suzetrigine supports the goal of moving beyond relieving pain to doing so safely, without perpetuating cycles ...